Analyst Ratings for Ovid Therapeutics Inc (OVID)
OVID Rating Summary
OVID Price Target Summary
- Highest: $7.00 (Oppenheimer)
- Lowest: $4.00 (H.C. Wainwright)
- Average: $5.06
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$5.06 (+111.8%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
Rating Score: 7.8 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/22/2025 | LifeSci Capital | N/A | New Coverage | Outperform (N/A) |
4.00 (N/A) |
1.47 (2.39) |
62.59% | Details |
| 12/11/2025 | Roth/MKM » Updated 3/19/2026 |
Boobalan Pachaiyappan | New Coverage | Buy (N/A) |
5.00 (3.00) |
1.57 (2.39) |
52.23% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
